Synthomer PLC (LSE:SYNT) - Share price


Stock Report

Synthomer PLC SYNT

Last Price
GBX531.50

Day Change
2.50|0.47%

As of 26/07/2021
17:32:16 BST | GBX
Minimum 15 Minutes Delay.

Last Close529.00p
Day Range525.50 - 535.00
Mkt Cap2.26Bil
52-Wk Range276.20 - 564.50
Yield %2.21
ISINGB0009887422
Volume904,667
P/E769.23
P/S0.01
P/CF0.12

Share Price

Total Returns 26/07/2021

 Chg (%)  
More ...
Synthomer PLC4.94 
FTSE 100 TR GBP-1.45
 
Financials
201820192020
More ...
Income Statement
Turnover1,618.901,459.101,644.20
Operating Profit122.50116.20157.50
Net Profit103.3085.60-1.50
Reported EPS27.3021.400.70
Balance Sheet
Current Assets471.70421.00635.90
Non Current Assets812.70838.401,423.20
Total Assets1,284.401,259.402,059.10
Current Liabilities386.30298.30468.40
Total Liabilities---
Total Equity485.00670.50628.10
Cash Flow
Operating Cash Flow120.40163.00218.20
Net Change in Cash9.2024.7094.20

Regulatory News

DateAuthor Headline
22/07/2021James Gard Stock of the Week: All Posts
Every week we ask our Twitter followers which stocks we should write about - previous winners include Tesla, Amazon and Apple
12/07/2021James Gard Top FTSE Dividend Paying Stocks
UPDATED July 2021: Investors are eagerly awaiting results season for updates on dividends and buybacks
24/11/2020Damien Conover Covid Vaccine Breakthrough: the Morningstar View
Morningstar analyst Damien Conover looks in detail at the latest vaccine developments from AstraZeneca and Pfizer/BioNTech
Director Dealings
TradedActionNotifierPriceAmountValue
More ...
06/07/2021DMr. Calum Grigor MacLean515.5017,39689,676.00
05/07/2021DMs. Caroline Johnstone506.36191967.00
05/05/2021PurchaseMs. Holly Van Deursen517.004,75024,558.00
26/03/2021PurchaseMr. Calum Grigor MacLean463.0031,979148,063.00

Company Profile

Synthomer PLC is a specialty chemicals company. It supplies a variety of chemicals including latex & adhesives, which are used in a wide range of markets such as construction, coatings, textiles, paper, and healthcare. The company's products include styrene-butadiene rubber, which is used to make coated paper, packaging, bindings for carpet, foam mattresses, pillows, & shoes; and nitrile butadiene latex used to make medical gloves and catheters, among others. The company organizes itself into four segments: performance elastomers, functional solutions, industrial specialties, and acrylate monomers. A vast majority of the company's revenue is generated by the performance elastomers & functional solutions segments combined, and roughly half of the company's revenue is earned in Europe.

Sector

Specialty Chemicals

Index

FTSE 250 , FTSE 350 , FTSE All Share

Next Event 05/08/2021

Half-Yearly Results
Ratios
Comp
More ...
PER (E)702.29
Div Yld (E)2.36
PEG (E)0.00
ROCE3.21
Op Mrgn0.10
EPS Grwth-0.15
Dividends
PreviousLatest
More ...
Record Date23/10/2004/06/21
Ex-Div22/10/2003/06/21
Paid10/11/2005/07/21
Amnt3.008.60
Directors
More ...
Non-Executive DirectorDato Hau Hian Lee
Non-Executive Director, Senior Independent DirectorMr. Brendan Connolly
Executive Director, Group Chief Executive OfficerMr. Calum Grigor MacLean
Non-Executive DirectorThe Honourable Alexander Gordon Catto
Non-Executive DirectorDr. Just Jansz
Non-Executive Director, ChairmanMs. Caroline Johnstone
Executive Director, Chief Financial OfficerMr. Stephen Guy Bennett
Non-Executive DirectorMs. Holly Van Deursen
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2021 Morningstar. All rights reserved.